PRC200-SS

From Wikipedia, the free encyclopedia
(Redirected from PRC050)
Jump to navigation Jump to search

Template:Short description Template:Drugbox

PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic.[1][2]

Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity,[3] precluding any further drug development.

References

<templatestyles src="Reflist/styles.css" />

  1. Script error: No such module "Citation/CS1".
  2. Script error: No such module "citation/CS1".
  3. Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Script error: No such module "Navbox". Template:Monoamine reuptake inhibitors